Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?

Intensive Care Medicine

Volumn 37, Issue 1, 2011, Pages 141-146

  Ozyilmaz, Ezgi ^b   Ebinc, Fatma Ayerden ^a   Derici, Ulver ^a   Gulbahar, Ozlem ^a   Goktas, Guleser ^a   Elmas, Cigdem ^a   Oguzulgen, I Kivilcim ^a   Sindel, Sukru ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE

Author keywords

Colistin; i NOS; N Acetylcysteine (NAC); Nephrotoxicity; NT 3; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; COLISTIN; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; NEUROTROPHIN 3; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; UREA NITROGEN BLOOD LEVEL;

ACETYLCYSTEINE; ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; KIDNEY DISEASES; LUNG; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78751646280     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-2038-7     Document Type: Article

References (18)

1. AS Michalopoulos ME Falagas 2008 Colistin and polymyxin B in critical care Crit Care Clin 24 377 391 1:CAS:528:DC%2BD1cXmtFSnsrg%3D 10.1016/j.ccc.2007.12.003 18361952 (Pubitemid 351400615)
2. AS Michalopoulos S Tsiodras K Rellos S Menzelopoulos ME Falagas 2005 Colistin treatment in patients with ICU-acquired infections caused by multidrug resistant gram negative bacteria: the renaissance of an old antibiotic Clin Microbiol Infect 11 115 121 1:CAS:528:DC%2BD2MXit1amtbo%3D 10.1111/j.1469-0691. 2004.01043.x 15679485 (Pubitemid 40259694)
3. AP Zavacki LZ Goldani J Li RL Nation 2007 Polymyxin B for the treatment of multidrug resistant pathogens: a critical review J Antimicrob Chemother 60 1206 1215 10.1093/jac/dkm357 (Pubitemid 350168315)
4. ME Falagas SK Kasiakou 2005 Colistin: the revival of polymyxins for the management of multidrug resistant gram negative bacterial infections Clin Infect Dis 40 1333 1341 1:CAS:528:DC%2BD2MXktlajsro%3D 10.1086/429323 15825037 (Pubitemid 40570245)
5. ML Aitio 2005 N-acetylcysteine-passé-partout or much ado about nothing? Br J Clin Pharmacol 61 5 15 10.1111/j.1365-2125.2005.02523.x
6. F Petronilho L Constantino B de Souza A Reinke MR Martins CM Fraga C Ritter F Dal-Pizzol 2009 Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats Nephrol Dial Transplant 24 2077 2082 1:CAS:528:DC%2BD1MXnslKjsb8%3D 10.1093/ndt/gfn774 19204016
7. SM Bagshaw FA McAlister BJ Manns WA Ghali 2006 Acetylcysteine in the prevention of contrast induced nephropathy: a case study of the pitfalls in the evaluation of evidence Arch Intern Med 166 161 166 1:CAS:528: DC%2BD28XhtFagtLs%3D 10.1001/archinte.166.2.161 16432083 (Pubitemid 43144938)
8. KS McCarty Jr RS Miller 1985 Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies Arch Pathol Lab Med 109 716 721 3893381
9. N Markou H Apostolakos C Koumoudiou M Athanasiou A Koutsoukou I Alamanos L Gregorakos 2003 Intravenous colistin in the treatment of sepsis from multidrug resistant gram negative bacilli in critically ill patients Crit Care 7 R78 R83 10.1186/cc2358 12974973
10. ME Falagas SK Kasiakou 2006 Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit Care 10 R27 10.1186/cc3995 16507149 (Pubitemid 47079794)
11. MD Reed RC Stern MA O'Riordan JL Blumer 2001 The pharmacokinetics of colistin in patients with cystic fibrosis J Clin Pharmacol 41 645 654 1:CAS:528:DC%2BD3MXks1Kgs74%3D 10.1177/00912700122010537 11402633 (Pubitemid 32493359)
12. ME Falagas M Rizos IA Bliziotis K Rellos SK Kasiakou A Michalopoulos 2005 Toxicity after prolonged (more than four weeks) administration of intravenous colistin BMC Infect Dis 5 1 10.1186/1471-2334-5-1 15642116 (Pubitemid 41363780)
13. PNR Dekhuijzen 2004 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Eur Respir J 23 629 636 1:CAS:528:DC%2BD2cXjslCitLs%3D 10.1183/09031936.04.00016804 15083766 (Pubitemid 38456009)
14. N Senoglu MF Yuzbasioglu M Aral M Ezberci EB Kurutas E Bulbuloglu F Ezberci H Oksuz P Ciragil 2008 Protective effects of N-acetylcysteine and beta-glucan pretreatment on oxidative stress in cecal ligation and puncture model of sepsis J Invest Surg 21 237 243 1:STN:280:DC%2BD1M%2Fos1ahug%3D%3D 10.1080/08941930802180136 19160131
15. E Erturk B Cekic S Geze M Kosucu I Coskun A Eroglu H Ulusoy A Mentese C Karahan S Kerimoglu 2009 Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia-reperfusion injury Eur J Anaesthesiol 26 279 284 1:CAS:528:DC%2BD1MXntFeitbs%3D 10.1097/EJA.0b013e32831c87c7 19401659
16. BH Ali S Al Salam I Al-Husseini A Nemmar 2009 Comparative protective effect of N-acetyl cysteine and tetramethylpyrazine in rats with gentamicin nephrotoxicity J Appl Toxicol 29 302 308 1:CAS:528:DC%2BD1MXls1emsr0%3D 10.1002/jat.1409 19117019
17. J Luo T Tsuji H Yasuda Y Sun Y Fujigaki A Hishida 2008 The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats Nephrol Dial Transplant 23 2198 2205 1:CAS:528:DC%2BD1cXnvFSgs74%3D 10.1093/ndt/gfn090 18385389 (Pubitemid 351957613)
18. R Ghaznavi M Kadkhodaee 2007 Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity Arch Toxicol 81 453 457 1:CAS:528:DC%2BD2sXls1Sgs7k%3D 10.1007/s00204-006-0157-2 17039356 (Pubitemid 46991724)